Li Y, Gao Y, Chen J, et al
R., Schrder, O., Herrmann, E., & Blumenstein, I
J Cosmet Dermatol 16(2):253257 Zolghadri S, Beygi M, Mohammad TF, Alijanianzadeh M, Pillaiyar T, Garcia-Molina P et al (2023) Targeting tyrosinase in hyperpigmentation: current status, limitations and future promises
Therefore, Si-based agent are considered excellent therapeutic agent for symptom relief and sustained remission of UC
Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S
[18] [19] According to a 1961 study, patients with addiction who got NAD+ at a moderate IV drip rate (no more than 35 drops per minute) reported no distress but those who received it at a quicker drip rate complained of headache and shortness of breath